SpyGlass Pharma Acquires Advanced Vision Science for $13 Million

08:54 AM EDT, 10/01/2026 (MT Newswires) -- SpyGlass Pharma (SGP) acquired Advanced Vision Science, an ophthalmic medical device company, for about $13 million in cash, the company said Thursday. Advanced Vision Science is a unit of Japanese pharmaceutical Santen Pharmaceutical, and is the current supplier of SpyGlass' intraocular lenses in its phase 3 registrational trials evaluating its product candidate candidate, the BIM-IOL System, SpyGlass said. Under deal terms, Advanced Vision Science will become the exclusive manufacturer and supplier of several types of intraocular lenses to Santen Pharmaceutical for commercialization in Japan, according to a statement. SpyGlass Pharma further said that Advanced Vision Science will continue to license its glistening-free hydrophobic acrylic lens material to Bausch + Lomb (BLCO), and manufacture products for other companies.